- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04245384
Dietitian Online - Internet-based Dietetic Treatment Within Health Care Services (DiOn)
November 3, 2022 updated by: Umeå University
The project aims to investigate the effect of internet-based dietetic treatment (IDT) on patients, dietitians, and society.
The project will show:
- If IDT is equivalent to traditional dietetic treatment with physical meetings
- Patients' attitudes to, and experiences of, meeting a dietician through video calls
- How the dietician's work environment and working methods are affected by IDT
- If there are subgroups of patients where IDT is more or less appropriate
- Health economic and environmental consequences of IDT The major shortage of dietitians leaves patients with non-communicable diseases (NCD) without qualified dietary treatment. In a pilot study, the investigators have shown that IDT has great potential to streamline healthcare and increase accessibility. In the project Dietitian online, the investigators will conduct an RCT with 400 NCD-patients allocated to either IDT or standard dietetic treatment to see if IDT affect treatment outcome and whether IDT is appropriate for everyone. Even though internet-based treatment (IT) increases rapidly in society, there is little knowledge about the patients' experiences and how healthcare personnel incorporates IT in their daily work. The investigators will conduct qualitative studies to meet this knowledge gap. General assumptions are that IT is beneficial for society, both economically and environmentally, but very few studies have been done. The project will incorporate a full health-economic evaluation, including environmental impact.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
400
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Petra M Rydén, PhD
- Phone Number: +46907869557
- Email: petra.ryden@umu.se
Study Contact Backup
- Name: Sarah Persson, BSc
- Phone Number: +46907868069
- Email: sarah.persson@umu.se
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
seeking/being referred to a dietitian for the treatment of obesity (BMI≥25) or obesity in combination with:
- type 2 diabetes (HbA1c>48mmol/mol) and/or
- elevated blood lipids (total cholesterol >4,5 mmol/l and/or LDL >2,5 mmol/l and/or triglycerides >2,0 mmol/l) and/or
- high blood pressure (>140/90 hg)
Exclusion Criteria:
- other diagnoses requiring/might require nutritional treatment (eg cancer, COPD)
- dementia
- severe impairment of sight, hearing, or other disability where internet-based dietetic treatment is deemed difficult
- pregnancy
- need for interpreter
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Internet-based treatment
Internet-based dietetic treatment with video calls, no physical meetings
|
The dietitian meets the patient through video calls, no physical meetings
|
|
ACTIVE_COMPARATOR: Standard treatment
Dietetic treatment with physical meetings
|
The dietitian meets the patient through physical meetings
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in dietary intake
Time Frame: Change from baseline to three, six and twelve months after first treatment session
|
Dietary intake will be assessed using the Swedish National Food Administrations Food Index (minimum value 0, maximum value 12, higher score indicates a healthier diet).
Intake of fruit and vegetables in grams, as well as intake of discretionary calories (sweets, snacks, fast food, sugary drinks, pastries), will also be assessed.
|
Change from baseline to three, six and twelve months after first treatment session
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in participant alliance to dietitian
Time Frame: Change from baseline to three and six months after first treatment session
|
Alliance between patient and dietitian, measured with Working Alliance Inventory - Short (WAI-S, minimum value 12, maximum value 84, higher score indicates higher alliance to dietitian)
|
Change from baseline to three and six months after first treatment session
|
|
Change in participant activation
Time Frame: Change from baseline to six months after first treatment session
|
Patient activation (readiness to behavioral change), measured with Patient Activation Measure (PAM, (minimum value 0, maximum value 100, higher score indicates a higher activation (better)).
|
Change from baseline to six months after first treatment session
|
|
Change in participant motivation
Time Frame: Change from baseline to three. six and twelve months after first treatment session
|
Patient motivation (personal motivation to behavioral change), measured with VAS-scale 0-100, where higher score indicates higher motivation to behavioral change.
|
Change from baseline to three. six and twelve months after first treatment session
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in body weight
Time Frame: Change from baseline to three, six and twelve months after first treatment session
|
Self reported body weight
|
Change from baseline to three, six and twelve months after first treatment session
|
|
Change in physical activity
Time Frame: Change from baseline to three, six and twelve months after first treatment session
|
Physical activity, measured as average physical activity level (PAL) at work and at leisure time using a validated two-question questionnaire.
PAL-levels from the questionnaire range between 1.4 - 2.3, where a higher score indicates higher physical activity
|
Change from baseline to three, six and twelve months after first treatment session
|
|
Change in health-related quality of life
Time Frame: Change from baseline to six months after first treatment session
|
Health-related quality of life, measured with EQ-5D (minimum value 0, maximum value 1 where a higher value indicates higher quality of life
|
Change from baseline to six months after first treatment session
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Petra M Rydén, PhD, Umeå University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
March 1, 2023
Primary Completion (ANTICIPATED)
December 1, 2024
Study Completion (ANTICIPATED)
December 1, 2024
Study Registration Dates
First Submitted
January 21, 2020
First Submitted That Met QC Criteria
January 27, 2020
First Posted (ACTUAL)
January 28, 2020
Study Record Updates
Last Update Posted (ACTUAL)
November 4, 2022
Last Update Submitted That Met QC Criteria
November 3, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UmUDiOn
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight and Obesity
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
National Taiwan University HospitalCompleted
-
PfizerNot yet recruitingObesity | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Overweight or Obesity | Overweight and/or Obesity | Nutritional and Metabolic DiseasesUnited States
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasRecruitingPediatric Obesity | Pediatric Overweight | Overweight , ObesityUnited States
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
Clinical Trials on Internet-based dietetic treatment with video calls
-
Okan UniversityUnknown
-
Universitat Jaume IRecruitingProlonged Grief DisorderSpain
-
Aarhus University HospitalUniversity of AarhusCompletedAnxiety Disorders | Anxiety StateDenmark
-
Chinese University of Hong KongCompletedCOMBO Condition | STIGMA Condition | INTERACT Condition | CONTROL ConditionHong Kong
-
Örebro County CouncilÖrebro University, Sweden; Stiftelsen Professor Bror Gadelius Minnesfond; Regional... and other collaboratorsCompletedAutism Spectrum DisorderSweden
-
Karolinska InstitutetKarolinska University HospitalCompletedAtrial Fibrillation | ArrythmiaSweden
-
Gerhard AnderssonCompleted
-
Linkoeping UniversityUppsala UniversityCompletedBack Pain Lower Back ChronicSweden
-
University of VermontUniversity of ArkansasCompleted
-
Peking UniversityRecruiting